News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Servier To Teva Pharmaceutical Industries Limited (TEVA) Fined $582.2 Million on Generic Delays


7/9/2014 7:23:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Les Laboratoires Servier and five makers of generic drugs, including Teva Pharmaceutical Industries Ltd. (TEVA), were fined 427.7 million euros ($582.2 million) by the European Union over agreements that delayed the release of cheaper versions of a hypertension treatment.

Servier, the inventor of the drug, received the largest penalty -- 331 million euros -- for hampering the generic entry of perindopril. Teva was fined 15.6 million euros.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES